News und Analysen
Energy Stocks Bullish, But Futures Market Signals Trouble Ahead
The Energy Select Sector SPDR Fund (NYSEARCA: XLE) was trading higher for the fifth session in a row on July 24, extending that streak with a gap up at the open.
However, some analysts are
Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?
The recent rally in erstwhile tech leader Cloudflare Inc. (NYSE: NET) is a good reminder of why it’s important to stay up to speed on sector rotation, as it can have a big impact on your overall
Will Q2 Earnings Propel Payment Processor Shift4?
Payment processing specialist Shift4 Payments Inc. (NYSE: FOUR) formed a bullish base below resistance at $76.40. Its second-quarter earnings report on August 3 is a possible catalyst for a
It's Not a Stretch to Say Under Armour Stock Has Bottomed
When Under Armour, Inc. (NYSE: UAA) reports quarterly results next week, Wall Street won’t be expecting much — and that’s a good thing.
Analysts project that the athletic clothing manufacturer will
Sensation: Vollständige Krebsheilung - Massives Kaufsignal. Neuer 202% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensation: Vollständige Krebsheilung - Massives Kaufsignal. 202% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)
25.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Sirius-ly? Sirius XM Stock Squeezes 40% in 3 Hours
The Liquid Metal and Octane hard rock stations aren’t the only things making noise at Sirius XM Holdings Inc. (NASDAQ:SIRI) these days.
On Thursday, shares of the nation’s top satellite radio
AI Over? Is Slowdown in ChatGPT Traffic a Sign of AI Fatigue?
2023 will be remembered as the breakout year for artificial intelligence (AI), with credit given to the explosive viral growth of ChatGPT. The ChatGPT broke records when it surpassed over 100
3 Consumer Discretionary Stocks That Still Have Pricing Power
What’s one of the best predictors of stock price performance? If you said earnings growth, you’re right. But what is a reliable indicator of earnings growth? That would be pricing power. A common
Ross Stores Fashioning Growth: Analysts See Double-Digit EPS Rise
Ross Stores Inc. (NASDAQ: ROST) is trading higher for the week, following news that the company is opening new locations at a fast pace and is on track to add about 100 new stores during fiscal
Krebs erfolgreich geheilt - Klinische Studie mit sensationellen Ergebnissen. Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
Krebs erfolgreich geheilt - Klinische Studie mit sensation. Ergebnissen. 202% Biotech Hot Stock nach 134.452% mit Biogen
24.07.23 08:02
London (www.aktiencheck.de , Anzeige)
Winners And Losers In The Oilfield Supercycle
There are no losers in the oil field super cycle, only winners, but winning is relative. While the signs are good that the spending in upstream, natural gas, and efficiency will continue, 1
Did CSX Corporation’s Rebound Just Go Off The Rails?
CSX Corporation (NASDAQ: CSX) stock has been trying hard to get off a technical bottom, and the recovery might have gone off the rails. The Q2 results were less than expected and caused shares
IBM Is The Perfect Example Of Why Size Matters: An Earnings Story
International Business Machines (NYSE: IBM) share rose by as much as 3.0% to mark the high for Thursday's trading session. The reaction came from the company's second quarter 2023 earnings
2 Fintech Stocks to Buy Now and 1 to Avoid
Youth will be served. That’s how I would explain the speed and pervasiveness with which financial technology (fintech) has disrupted the financial sector. Millennial and Gen-Z investors have grown
Biotech Hot Stock meldet großartige Studienergebnisse - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
Biotech Hot Stock meldet großartige Studienergebnisse - Kaufsignal. 202% Biotech Aktientip nach 10996% mit Pfizer ($PFE)
21.07.23 08:02
London (www.aktiencheck.de , Anzeige)
American Airlines Beats Earnings, Thinking Of Buying?
Airline giant American Airlines Group (NASDAQ: AAL) reported second-quarter 2023 earnings results. The stock is trading down 6% in early trading as investors digest the report, perhaps providing
3 Undervalued Large-Cap Stocks That Won't Be for Long
The market rally is starting to extend beyond the “Magnificent 7” tech stocks. Yet many analysts and economists still believe investors may be in for a nasty pullback before the year ends.
Market
Abbott Laboratories Has the Prescription for Higher Share Prices
Abbott Laboratories (NYSE: ABT) is a tale of two stories. The first is its recovery from the COVID-19 boost and bubble. The second is the underlying core business, which is as strong as ever.
Will a Decrease in Housing Starts Hurt Homebuilder Stocks?
Homebuilders traded lower as a group on July 19, ending the session down 0.20% after the National Association of Homebuilders reported that June housing starts fell more than expected.
As a
Grid Dynamics Earns Membership in Microsoft’s Azure Migration and Modernization Program
Grid Dynamics Earns Membership in Microsoft’s Azure Migration and Modernization Program - Enabling Its Clients to Accelerate Time to Value on Cloud Transformation Initiatives and Invest in
Grid Dynamics wird Mitglied in Microsofts Azure Migration and Modernization Program
Grid Dynamics wird Mitglied in Microsofts Azure Migration and Modernization Program und ermöglicht seinen Kunden damit, den „Time-to-Value“ bei Cloud-basierten Transformationsinitiativen zu
Hershey's Stock Dip Presents a Sweet Opportunity
In May 2023, The Hershey Company (NYSE: HSY) launched a limited edition churro-flavored Kit Kat just in time for summer. Since then, approximately 10% has been trimmed from the leading U.S
Four Reasons Why Apple Could Soar To New Highs In Q3
If you look at the chart of Apple’s (NASDAQ: AAPL) stock price and wonder if it can bob to another new high, the odds are high that it can do so. This is among the world’s most-followed
Profits Decline At Goldman Sachs, Time To Pick Up Cheap Shares?
Most investors may be disappointed that the mystical firm, The Goldman Sachs Group (NYSE: GS), a name often synonymous with the creme de la creme on Wall Street, has reported declining business
Acumen Soars on Alzheimer's Study...Street Sees It Doubling
Two years removed from an IPO, Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) looks like it made a good decision to go public. Shares of the Charlottesville, Virginia-based biotechnology company